Dyslipidaemia	B:C0242339
and	O
Medical	O
Outcome	O
(	O
Health	O
Related	O
Quality	O
of	O
Life	O
)	O
in	O
Patients	O
with	O
Schizophrenia	O
Taking	O
Antipsychotics	O
in	O
Enugu	O
,	O
Nigeria	O
.	O

Dyslipidaemia	O
and	O
Medical	O
Outcome	O
(	O
Health	O
Related	O
Quality	O
of	O
Life	O
)	O
in	O
Patients	O
with	O
Schizophrenia	B:C0036341
Taking	O
Antipsychotics	O
in	O
Enugu	O
,	O
Nigeria	O
.	O

Dyslipidaemia	O
and	O
Medical	O
Outcome	O
(	O
Health	O
Related	O
Quality	O
of	O
Life	O
)	O
in	O
Patients	O
with	O
Schizophrenia	O
Taking	O
Antipsychotics	B:C0040615
in	O
Enugu	O
,	O
Nigeria	O
.	O

Dyslipidaemia	O
and	O
Medical	O
Outcome	O
(	O
Health	O
Related	O
Quality	O
of	O
Life	O
)	O
in	O
Patients	O
with	O
Schizophrenia	O
Taking	O
Antipsychotics	O
in	O
Enugu	O
,	O
Nigeria	B:C0028075
.	O

Determine	O
association	O
between	O
use	O
(	O
and	O
type	O
)	O
of	O
antipsychotics	B:C0040615
and	O
dyslipidaemia	O
in	O
newly	O
diagnosed	O
schizophrenia	O
patients	O
attending	O
Federal	O
Neuropsychiatric	I:C0019994
Hospital	I:C0019994
,	O
Enugu	O
.	O

Determine	O
association	O
between	O
use	O
(	O
and	O
type	O
)	O
of	O
antipsychotics	O
and	O
dyslipidaemia	B:C0242339
in	O
newly	O
diagnosed	O
schizophrenia	O
patients	O
attending	O
Federal	O
Neuropsychiatric	I:C0019994
Hospital	I:C0019994
,	O
Enugu	O
.	O

Determine	O
association	O
between	O
use	O
(	O
and	O
type	O
)	O
of	O
antipsychotics	O
and	O
dyslipidaemia	O
in	O
newly	O
diagnosed	O
schizophrenia	B:C0036341
patients	O
attending	O
Federal	O
Neuropsychiatric	I:C0019994
Hospital	I:C0019994
,	O
Enugu	O
.	O

Determine	O
association	O
between	O
use	O
(	O
and	O
type	O
)	O
of	O
antipsychotics	O
and	O
dyslipidaemia	O
in	O
newly	O
diagnosed	O
schizophrenia	O
patients	O
attending	O
Federal	B:C0019994
Neuropsychiatric	I:C0019994
Hospital	I:C0019994
,	O
Enugu	O
.	O

From	O
sixty	O
antipsychotic	B:C0040615
naive	O
patients	O
with	O
schizophrenia	O
and	O
sixty	O
first	O
-	O
degree	O
relatives	O
matched	O
for	O
gender	O
and	O
age	O
,	O
fasting	O
blood	I:C0430044
lipid	I:C0430044
profiles	I:C0430044
were	O
measured	O
at	O
baseline	O
and	O
after	O
twelve	O
weeks	O
.	O

From	O
sixty	O
antipsychotic	O
naive	O
patients	O
with	O
schizophrenia	B:C0036341
and	O
sixty	O
first	O
-	O
degree	O
relatives	O
matched	O
for	O
gender	O
and	O
age	O
,	O
fasting	O
blood	I:C0430044
lipid	I:C0430044
profiles	I:C0430044
were	O
measured	O
at	O
baseline	O
and	O
after	O
twelve	O
weeks	O
.	O

From	O
sixty	O
antipsychotic	O
naive	O
patients	O
with	O
schizophrenia	O
and	O
sixty	O
first	O
-	O
degree	O
relatives	O
matched	O
for	O
gender	O
and	O
age	O
,	O
fasting	B:C0430044
blood	I:C0430044
lipid	I:C0430044
profiles	I:C0430044
were	O
measured	O
at	O
baseline	O
and	O
after	O
twelve	O
weeks	O
.	O

Medical	B:C0451286
Outcome	I:C0451286
Study	I:C0451286
Short	I:C0451286
Form	I:C0451286
General	I:C0451286
Health	I:C0451286
Survey	I:C0451286
was	O
administered	O
to	O
patients	O
on	O
both	O
occasions	O
.	O

Fasting	B:C0430044
lipid	I:C0430044
profile	I:C0430044
changes	O
of	O
both	O
groups	O
were	O
compared	O
.	O

Mean	O
endpoint	O
of	O
total	B:C0543421
cholesterol	I:C0543421
(	O
total	O
cholesterol	I:C0543421
)	O
,	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
(	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
)	O
,	O
and	O
triglycerides	O
(	O
triglycerides	O
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
higher	O
than	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.5	O
versus	O
4.3	O
,	O
t	O
=	O
4.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
(	O
LDL	O
2.8	O
versus	O
2.6	O
,	O
t	O
=	O
14.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
and	O
(	O
triglycerides	O
1.3	O
versus	O
1.0	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
(	O
total	B:C0543421
cholesterol	I:C0543421
)	O
,	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
(	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
)	O
,	O
and	O
triglycerides	O
(	O
triglycerides	O
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
higher	O
than	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.5	O
versus	O
4.3	O
,	O
t	O
=	O
4.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
(	O
LDL	O
2.8	O
versus	O
2.6	O
,	O
t	O
=	O
14.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
and	O
(	O
triglycerides	O
1.3	O
versus	O
1.0	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
(	O
total	O
cholesterol	I:C0543421
)	O
,	O
low	B:C0023823
density	I:C0023823
lipoprotein	I:C0023823
(	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
)	O
,	O
and	O
triglycerides	O
(	O
triglycerides	O
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
higher	O
than	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.5	O
versus	O
4.3	O
,	O
t	O
=	O
4.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
(	O
LDL	O
2.8	O
versus	O
2.6	O
,	O
t	O
=	O
14.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
and	O
(	O
triglycerides	O
1.3	O
versus	O
1.0	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
(	O
total	O
cholesterol	I:C0543421
)	O
,	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
(	O
low	B:C0023823
density	I:C0023823
lipoprotein	I:C0023823
)	O
,	O
and	O
triglycerides	O
(	O
triglycerides	O
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
higher	O
than	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.5	O
versus	O
4.3	O
,	O
t	O
=	O
4.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
(	O
LDL	O
2.8	O
versus	O
2.6	O
,	O
t	O
=	O
14.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
and	O
(	O
triglycerides	O
1.3	O
versus	O
1.0	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
(	O
total	O
cholesterol	I:C0543421
)	O
,	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
(	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
)	O
,	O
and	O
triglycerides	B:C0041004
(	O
triglycerides	O
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
higher	O
than	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.5	O
versus	O
4.3	O
,	O
t	O
=	O
4.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
(	O
LDL	O
2.8	O
versus	O
2.6	O
,	O
t	O
=	O
14.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
and	O
(	O
triglycerides	O
1.3	O
versus	O
1.0	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
(	O
total	O
cholesterol	I:C0543421
)	O
,	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
(	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
)	O
,	O
and	O
triglycerides	O
(	O
triglycerides	B:C0041004
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
higher	O
than	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.5	O
versus	O
4.3	O
,	O
t	O
=	O
4.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
(	O
LDL	O
2.8	O
versus	O
2.6	O
,	O
t	O
=	O
14.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
and	O
(	O
triglycerides	O
1.3	O
versus	O
1.0	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
(	O
total	O
cholesterol	I:C0543421
)	O
,	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
(	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
)	O
,	O
and	O
triglycerides	O
(	O
triglycerides	O
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
higher	O
than	O
initial	O
values	O
(	O
total	B:C0543421
cholesterol	I:C0543421
4.5	O
versus	O
4.3	O
,	O
t	O
=	O
4.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
(	O
LDL	O
2.8	O
versus	O
2.6	O
,	O
t	O
=	O
14.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
and	O
(	O
triglycerides	O
1.3	O
versus	O
1.0	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
(	O
total	O
cholesterol	I:C0543421
)	O
,	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
(	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
)	O
,	O
and	O
triglycerides	O
(	O
triglycerides	O
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
higher	O
than	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.5	O
versus	O
4.3	O
,	O
t	O
=	O
4.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
(	O
LDL	B:C0023823
2.8	O
versus	O
2.6	O
,	O
t	O
=	O
14.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
and	O
(	O
triglycerides	O
1.3	O
versus	O
1.0	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
(	O
total	O
cholesterol	I:C0543421
)	O
,	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
(	O
low	O
density	I:C0023823
lipoprotein	I:C0023823
)	O
,	O
and	O
triglycerides	O
(	O
triglycerides	O
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
higher	O
than	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.5	O
versus	O
4.3	O
,	O
t	O
=	O
4.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
(	O
LDL	O
2.8	O
versus	O
2.6	O
,	O
t	O
=	O
14.3	O
,	O
p	O
<	O
0.0001	O
)	O
,	O
and	O
(	O
triglycerides	B:C0041004
1.3	O
versus	O
1.0	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
endpoint	O
of	O
high	B:C0023821
density	I:C0023821
lipoprotein	I:C0023821
(	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
lower	O
than	O
initial	O
values	O
(	O
1.1	O
versus	O
1.2	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
endpoint	O
of	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
(	O
high	B:C0023821
density	I:C0023821
lipoprotein	I:C0023821
)	O
in	O
mmol	O
/	O
l	O
for	O
cases	O
was	O
significantly	O
lower	O
than	O
initial	O
values	O
(	O
1.1	O
versus	O
1.2	O
,	O
t	O
=	O
12.1	O
,	O
p	O
<	O
0.0001	O
)	O
.	O

Prevalence	O
of	O
dyslipidaemia	B:C0242339
for	O
cases	O
was	O
13	O
%	O
.	O

Mean	O
endpoint	O
of	O
total	B:C0543421
cholesterol	I:C0543421
,	O
LDL	O
,	O
triglycerides	O
,	O
and	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
in	O
mmol	O
/	O
l	O
for	O
controls	O
was	O
not	O
significantly	O
different	O
from	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.30	O
versus	O
4.27	O
,	O
t	O
=	O
1.09	O
,	O
p	O
=	O
0.279	O
)	O
,	O
(	O
LDL	O
2.49	O
versus	O
2.46	O
,	O
t	O
=	O
1.28	O
,	O
p	O
=	O
0.205	O
)	O
,	O
(	O
triglycerides	O
0.96	O
versus	O
0.94	O
,	O
t	O
=	O
1.27	O
,	O
p	O
=	O
0.207	O
)	O
,	O
and	O
(	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
1.37	O
versus	O
1.38	O
,	O
t	O
=	O
1.61	O
,	O
p	O
=	O
0.113	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
,	O
LDL	B:C0023823
,	O
triglycerides	O
,	O
and	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
in	O
mmol	O
/	O
l	O
for	O
controls	O
was	O
not	O
significantly	O
different	O
from	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.30	O
versus	O
4.27	O
,	O
t	O
=	O
1.09	O
,	O
p	O
=	O
0.279	O
)	O
,	O
(	O
LDL	O
2.49	O
versus	O
2.46	O
,	O
t	O
=	O
1.28	O
,	O
p	O
=	O
0.205	O
)	O
,	O
(	O
triglycerides	O
0.96	O
versus	O
0.94	O
,	O
t	O
=	O
1.27	O
,	O
p	O
=	O
0.207	O
)	O
,	O
and	O
(	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
1.37	O
versus	O
1.38	O
,	O
t	O
=	O
1.61	O
,	O
p	O
=	O
0.113	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
,	O
LDL	O
,	O
triglycerides	B:C0041004
,	O
and	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
in	O
mmol	O
/	O
l	O
for	O
controls	O
was	O
not	O
significantly	O
different	O
from	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.30	O
versus	O
4.27	O
,	O
t	O
=	O
1.09	O
,	O
p	O
=	O
0.279	O
)	O
,	O
(	O
LDL	O
2.49	O
versus	O
2.46	O
,	O
t	O
=	O
1.28	O
,	O
p	O
=	O
0.205	O
)	O
,	O
(	O
triglycerides	O
0.96	O
versus	O
0.94	O
,	O
t	O
=	O
1.27	O
,	O
p	O
=	O
0.207	O
)	O
,	O
and	O
(	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
1.37	O
versus	O
1.38	O
,	O
t	O
=	O
1.61	O
,	O
p	O
=	O
0.113	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
,	O
LDL	O
,	O
triglycerides	O
,	O
and	O
high	B:C0023821
density	I:C0023821
lipoprotein	I:C0023821
in	O
mmol	O
/	O
l	O
for	O
controls	O
was	O
not	O
significantly	O
different	O
from	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.30	O
versus	O
4.27	O
,	O
t	O
=	O
1.09	O
,	O
p	O
=	O
0.279	O
)	O
,	O
(	O
LDL	O
2.49	O
versus	O
2.46	O
,	O
t	O
=	O
1.28	O
,	O
p	O
=	O
0.205	O
)	O
,	O
(	O
triglycerides	O
0.96	O
versus	O
0.94	O
,	O
t	O
=	O
1.27	O
,	O
p	O
=	O
0.207	O
)	O
,	O
and	O
(	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
1.37	O
versus	O
1.38	O
,	O
t	O
=	O
1.61	O
,	O
p	O
=	O
0.113	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
,	O
LDL	O
,	O
triglycerides	O
,	O
and	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
in	O
mmol	O
/	O
l	O
for	O
controls	O
was	O
not	O
significantly	O
different	O
from	O
initial	O
values	O
(	O
total	B:C0543421
cholesterol	I:C0543421
4.30	O
versus	O
4.27	O
,	O
t	O
=	O
1.09	O
,	O
p	O
=	O
0.279	O
)	O
,	O
(	O
LDL	O
2.49	O
versus	O
2.46	O
,	O
t	O
=	O
1.28	O
,	O
p	O
=	O
0.205	O
)	O
,	O
(	O
triglycerides	O
0.96	O
versus	O
0.94	O
,	O
t	O
=	O
1.27	O
,	O
p	O
=	O
0.207	O
)	O
,	O
and	O
(	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
1.37	O
versus	O
1.38	O
,	O
t	O
=	O
1.61	O
,	O
p	O
=	O
0.113	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
,	O
LDL	O
,	O
triglycerides	O
,	O
and	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
in	O
mmol	O
/	O
l	O
for	O
controls	O
was	O
not	O
significantly	O
different	O
from	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.30	O
versus	O
4.27	O
,	O
t	O
=	O
1.09	O
,	O
p	O
=	O
0.279	O
)	O
,	O
(	O
LDL	B:C0023823
2.49	O
versus	O
2.46	O
,	O
t	O
=	O
1.28	O
,	O
p	O
=	O
0.205	O
)	O
,	O
(	O
triglycerides	O
0.96	O
versus	O
0.94	O
,	O
t	O
=	O
1.27	O
,	O
p	O
=	O
0.207	O
)	O
,	O
and	O
(	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
1.37	O
versus	O
1.38	O
,	O
t	O
=	O
1.61	O
,	O
p	O
=	O
0.113	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
,	O
LDL	O
,	O
triglycerides	O
,	O
and	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
in	O
mmol	O
/	O
l	O
for	O
controls	O
was	O
not	O
significantly	O
different	O
from	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.30	O
versus	O
4.27	O
,	O
t	O
=	O
1.09	O
,	O
p	O
=	O
0.279	O
)	O
,	O
(	O
LDL	O
2.49	O
versus	O
2.46	O
,	O
t	O
=	O
1.28	O
,	O
p	O
=	O
0.205	O
)	O
,	O
(	O
triglycerides	B:C0041004
0.96	O
versus	O
0.94	O
,	O
t	O
=	O
1.27	O
,	O
p	O
=	O
0.207	O
)	O
,	O
and	O
(	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
1.37	O
versus	O
1.38	O
,	O
t	O
=	O
1.61	O
,	O
p	O
=	O
0.113	O
)	O
.	O

Mean	O
endpoint	O
of	O
total	O
cholesterol	I:C0543421
,	O
LDL	O
,	O
triglycerides	O
,	O
and	O
high	O
density	I:C0023821
lipoprotein	I:C0023821
in	O
mmol	O
/	O
l	O
for	O
controls	O
was	O
not	O
significantly	O
different	O
from	O
initial	O
values	O
(	O
total	O
cholesterol	I:C0543421
4.30	O
versus	O
4.27	O
,	O
t	O
=	O
1.09	O
,	O
p	O
=	O
0.279	O
)	O
,	O
(	O
LDL	O
2.49	O
versus	O
2.46	O
,	O
t	O
=	O
1.28	O
,	O
p	O
=	O
0.205	O
)	O
,	O
(	O
triglycerides	O
0.96	O
versus	O
0.94	O
,	O
t	O
=	O
1.27	O
,	O
p	O
=	O
0.207	O
)	O
,	O
and	O
(	O
high	B:C0023821
density	I:C0023821
lipoprotein	I:C0023821
1.37	O
versus	O
1.38	O
,	O
t	O
=	O
1.61	O
,	O
p	O
=	O
0.113	O
)	O
.	O

Subjects	B:C0080105
on	O
atypical	O
antipsychotics	O
had	O
higher	O
risk	O
for	O
dyslipidaemia	O
.	O

Subjects	O
on	O
atypical	O
antipsychotics	B:C0040615
had	O
higher	O
risk	O
for	O
dyslipidaemia	O
.	O

Subjects	O
on	O
atypical	O
antipsychotics	O
had	O
higher	O
risk	O
for	O
dyslipidaemia	B:C0242339
.	O

Use	O
of	O
antipsychotics	B:C0040615
was	O
significantly	O
associated	O
with	O
dyslipidaemia	O
.	O

Use	O
of	O
antipsychotics	O
was	O
significantly	O
associated	O
with	O
dyslipidaemia	B:C0242339
.	O

